1. Home
  2. TTE vs NVS Comparison

TTE vs NVS Comparison

Compare TTE & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TotalEnergies SE

TTE

TotalEnergies SE

HOLD

Current Price

$77.29

Market Cap

205.5B

Sector

Energy

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$155.52

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTE
NVS
Founded
1924
1895
Country
France
Switzerland
Employees
101513
75267
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5B
286.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TTE
NVS
Price
$77.29
$155.52
Analyst Decision
Hold
Hold
Analyst Count
8
5
Target Price
$76.63
$144.00
AVG Volume (30 Days)
1.4M
2.0M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
4.14%
2.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.83
$2.30
Revenue Next Year
N/A
$5.27
P/E Ratio
$12.60
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$57.40
$112.34
52 Week High
$94.17
$170.46

Technical Indicators

Market Signals
Indicator
TTE
NVS
Relative Strength Index (RSI) 19.73 60.58
Support Level $76.56 $149.49
Resistance Level $93.66 $158.80
Average True Range (ATR) 1.49 2.45
MACD -0.90 0.62
Stochastic Oscillator 2.67 91.19

Price Performance

Historical Comparison
TTE
NVS

About TTE TotalEnergies SE

TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2025, it produced 1.5 million barrels of liquids and 5.4 billion cubic feet of natural gas per day. At the end of 2025, reserves stood at 11.2 billion barrels of oil equivalent, 55% of which are liquids. During 2025, it had LNG sales of 43.9 million metric tons. The company owns interests in refineries with a capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 34 gigawatts.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: